BNP Paribas Exane raises Levi Strauss price target to $35
BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.
How this was made
The 30-second read
Why it matters
The higher target may prompt short‑term buying, but investors should watch upcoming guidance and DTC sales trends.
Market read
A fresh analyst upgrade provides a modest trading edge for LEVI investors.
What to watch
Tariff refund benefits may be temporary, and margin pressure could re‑emerge.
Background
Analyst price‑target revisions are common after earnings releases; this follows Levi Strauss' Q3 results showing modest revenue growth and a $0.48 EPS beat.
Ticker impact
BNP Paribas Exane raised its price target on Levi Strauss to $35, indicating a more bullish outlook.
potential upside as investors price in the higher target
Target raise signals improved expectations for revenue and margins, likely attracting demand.
Market effects
May lift sentiment for the broader apparel and consumer discretionary sector.
Limited to U.S. and European markets where Levi Strauss operates.
Modest, as the company is a mid-cap with niche exposure.
Counterpoint
Target raise could be premature given lingering direct‑to‑consumer weakness.
Key entities
- companyLevi Strauss & Co.
Apparel maker whose stock ticker is LEVI.
- analystBNP Paribas Exane
Research firm that raised the price target.
